Saturday, November 23, 2024
HomeTagsAntisense Oligonucleotide Therapeutics

Antisense Oligonucleotide Therapeutics

Vanda Pharmaceuticals and OliPass Announce Partnership to Develop Antisense Oligonucleotide Therapeutics

Vanda Pharmaceuticals Inc. and OliPass Corporation (OliPass) announced that they have entered into a research and development collaboration agreement to jointly develop a set...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics